"Designing Growth Strategies is in our DNA"
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of vitiligo by key countries
4.2. Pipeline analysis
4.3. Recent industry developments - mergers & acquisitions
4.4. Recent developments in R&D
5. Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Treatment
5.2.1. Topical Treatment
5.2.2. Light Therapy
5.2.3. Surgical Procedures
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Disease Type
5.3.1. Nonsegmental Vitiligo
5.3.2. Segmental Vitiligo
5.4. Market Analysis, Insights and Forecast – By End-user
5.4.1. Hospitals
5.4.2. Aesthetic Clinics
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Treatment
6.2.1. Topical Treatment
6.2.2. Light Therapy
6.2.3. Surgical Procedures
6.2.4. Others
6.3. Market Analysis – By Disease Type
6.3.1. Nonsegmental Vitiligo
6.3.2. Segmental Vitiligo
6.4. Market Analysis – By End-user
6.4.1. Hospitals
6.4.2. Aesthetic Clinics
6.4.3. Others
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Treatment
7.2.1. Topical Treatment
7.2.2. Light Therapy
7.2.3. Surgical Procedures
7.2.4. Others
7.3. Market Analysis – By Disease Type
7.3.1. Nonsegmental Vitiligo
7.3.2. Segmental Vitiligo
7.4. Market Analysis – By End-user
7.4.1. Hospitals
7.4.2. Aesthetic Clinics
7.4.3. Others
7.5. Market Analysis – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia pacific Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Treatment
8.2.1. Topical Treatment
8.2.2. Light Therapy
8.2.3. Surgical Procedures
8.2.4. Others
8.3. Market Analysis – By Disease Type
8.3.1. Nonsegmental Vitiligo
8.3.2. Segmental Vitiligo
8.4. Market Analysis – By End-user
8.4.1. Hospitals
8.4.2. Aesthetic Clinics
8.4.3. Others
8.5. Market Analysis – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Treatment
9.2.1. Topical Treatment
9.2.2. Light Therapy
9.2.3. Surgical Procedures
9.2.4. Others
9.3. Market Analysis – By Disease Type
9.3.1. Nonsegmental Vitiligo
9.3.2. Segmental Vitiligo
9.4. Market Analysis – By End-user
9.4.1. Hospitals
9.4.2. Aesthetic Clinics
9.4.3. Others
9.5. Market Analysis – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Treatment
10.2.1. Topical Treatment
10.2.2. Light Therapy
10.2.3. Surgical Procedures
10.2.4. Others
10.3. Market Analysis – By Disease Type
10.3.1. Nonsegmental Vitiligo
10.3.2. Segmental Vitiligo
10.4. Market Analysis – By End-user
10.4.1. Hospitals
10.4.2. Aesthetic Clinics
10.4.3. Others
10.5. Market Analysis – By Country/Sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. Incyte Corporation
11.5.2. Astellas Pharma Inc.
11.5.3. Bausch Health Companies Inc.
11.5.4. Baxter International Inc.
11.5.5. Dr. Reddy’s Laboratories Ltd.
11.5.6. Pfizer Inc.
11.5.7. STRATA Skin Sciences
12. Strategic Recommendation